Online edition of India's National Newspaper
Saturday, Jan 03, 2009
ePaper | Mobile/PDA Version
Google



Andhra Pradesh
News: ePaper | Front Page | National | Tamil Nadu | Andhra Pradesh | Karnataka | Kerala | New Delhi | Other States | International | Opinion | Business | Sport | Miscellaneous | Engagements |
Advts:
Retail Plus | Classifieds | Jobs | Obituary |



Andhra Pradesh - Visakhapatnam Printer Friendly Page   Send this Article to a Friend

Weight-loss pill banned

Staff Reporter

VISAKHAPATNAM: The weight-loss pill ‘Rimonabant’ is said to cause psychiatric side effects, including suicidal tendencies among users.

Research conducted on the directions of the Drugs Controller General of India has confirmed this and hence the pill has been banned, according to Drugs Controller Ravi Udaya Bhaskar. About 12 companies in India are manufacturing the anti-obesity drug.

He directed the distributors and chemists not to purchase or sell the following brand names containing (Rimonabant): Slimona, Rimoslim, Riobant, Zimulti, Monaslim and Acomplia.

Doctors are asked not to prescribe these drugs and consumers have been advised not to use them.

Printer friendly page  
Send this article to Friends by E-Mail



Andhra Pradesh

News: ePaper | Front Page | National | Tamil Nadu | Andhra Pradesh | Karnataka | Kerala | New Delhi | Other States | International | Opinion | Business | Sport | Miscellaneous | Engagements |
Advts:
Retail Plus | Classifieds | Jobs | Obituary | Updates: Breaking News |




News Update



The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | Publications | eBooks | Images | Ergo | Home |

Copyright © 2009, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu